サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：デジタルPCR市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1303128

デジタルPCR市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Type, By Component, By Application, By End User, By Region and Competition

出版日
ページ情報
英文 113 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

デジタルPCR市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のデジタルPCR市場は、予測期間2024～2028年に安定したCAGRの成長を示すと予測されています。

これは、血液がん、肺がん、脳腫瘍のような様々なタイプのがんの有病率の増加、発展途上国の人々のヘルスケア支出の需要の急増に起因しています。加えて、世界中で様々な疾患の早期かつ正確な診断に対する需要が高まっていることが、分子診断に対する需要を大幅に増加させ、それによって世界のデジタルPCR市場の成長を支えています。さらに、デジタルPCR技術の進歩と製品発売の増加は、予測期間のデジタルPCR市場の需要を増加させました。PCR技術の進歩を開発するための研究開発活動の需要とデジタルPCRの開発のための企業間の共同契約の増加は、予測期間のデジタルPCRの世界市場を押し上げます。世界保健機関（WHO）によると、2021年12月には、2億7,300万人の症例が診断され、約530万人がCOVID-19により世界で死亡したと報告されています。

デジタルPCRデバイスの採用増加

世界中で感染症、がん、遺伝性疾患の罹患率が上昇し、新興国ではこれらの疾患の有病率が増加しているにもかかわらず、デジタルPCR技術の採用は都市部では限定的です。しかし、デジタルPCRの利用可能性に関する認知度を高めるために大手企業が行ったイニシアチブ、異なる慢性疾患の診断のための政府機関による投資とイニシアチブの増加、および強力な流通網の確立は、予測期間における市場全体の成長を後押しします。さらに、Digital PCR技術の進歩は、液滴、チップベースPCRなどとともに、今後数年間の市場成長に新たな展望を生み出すと期待されています。その上、特に病原体の遺伝子変異検出のための実験室におけるDigital PCRの採用の増加は、今後数年間の市場成長をサポートすると予想されます。さらに、食品微生物学と獣医学における製品アプリケーションの増加は、予測期間においてデジタルPCR市場を推進します。さらに、COVID-19パンデミックの突然の発生と広がり、COVID-19検査における異なるタイプのPCRデバイスの広範な使用は、デジタルPCR市場を含む異なるタイプのPCR市場の成長に新たな展望を生み出しています。2022年、米国では合計96,091,120件のCOVID-19症例がカウントされました。

デジタルPCRにおける研究開発活動のための資金増加

COVID19パンデミックのため、ヘルスケアと研究機関セクターでDigital PCRの予想外の需要が増加しました。パンデミックはデジタルPCR市場の成長を高める上で重要な役割を果たしています。がんのような感染症の流行も増加し、病気の診断と検出の必要性を説明しています。このため、研究開発分野の資金も増加しています。異なる目的でのデジタルPCRとチップベースPCRの使用を含む研究開発活動への資金提供の増加は、その使用を増加させ、予測期間中に世界市場拡大の新たな機会を開くと期待されています。

利用可能なカスタマイズ

TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 デジタルPCRの世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別（Droplet Digital PCR、Chip Based Digital PCR、その他）
    • コンポーネント別（システム、キット・アッセイ、試薬・消耗品）
    • 用途別（腫瘍学、感染症、希少疾患、生殖遺伝学、その他）
    • エンドユーザー別（学術・研究機関、バイオテクノロジー・製薬企業、病院・クリニック、その他）
    • 地域別
    • 企業別（2022年）
  • 市場マップ
    • タイプ別
    • コンポーネント別
    • 用途別
    • エンドユーザー別
    • 地域別

第6章 北米のデジタルPCR市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • コンポーネント別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のデジタルPCR市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • コンポーネント別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋のデジタルPCR市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • コンポーネント別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のデジタルPCR市場の展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • タイプ別
    • コンポーネント別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのデジタルPCR市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • コンポーネント別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト
    • トルコ

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併・買収
  • 製品発表

第13章 競合情勢

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials（As reported）
  • Recent Developments
  • SWOT Analysis
    • Bio-Rad Laboratories, Inc.
    • Fluidigm Corporation
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • QIAGEN N.V.
    • Thermo Fisher Scientific Inc.
    • Genetron Holdings Limited
    • Naveris, Inc.
    • SAGA Diagnostics
    • Precigenome LLC

第14章 戦略的提言

目次
Product Code: 14589

Global Digital PCR Market is anticipated to witness a growth of steady CAGR in the forecast period 2024-2028. This can be ascribed to the increasing prevalence of various types of cancer like blood cancer, lung cancer, and brain tumor and the surge in demand for healthcare expenditure of people in developing countries. Besides, the growing demand for early and accurate diagnosis of various diseases across the globe has significantly increased the demand for molecular diagnostics, thereby supporting the growth of the global digital PCR market. Additionally, advancements in digital PCR technology and an increasing number of product launches increased the demand for the digital PCR market for the forecast period. The demand in research and development activities for developing advancement in PCR technology and rising collaboration agreements between companies for the development of digital PCR boost the global digital PCR market for the forecast period. According to World Health Organization (WHO), in December 2021, 273 million cases were diagnosed, and approximately 5.3 million deaths have been reported globally due to COVID-19.

Rising Adoption of Digital PCR Devices

Despite the rising incidence of infectious diseases, cancer, and genetic disorders across the globe and the increasing prevalence of these conditions in emerging countries, the adoption of digital PCR techniques is limited in urban regions. However, initiatives taken by leading players to enhance awareness about digital PCR availability, increasing investments and initiatives by government organizations for the diagnosis of different chronic diseases, and the establishment of a strong distribution network will boost the overall market growth in the forecast period. Additionally, advancement in Digital PCR technology, along with droplet, and chip-based PCR, among others, is expected to create new prospects for market growth in the coming years. Besides, the increasing adoption of Digital PCR in laboratories for the detection of genetic mutation detection of pathogens, among others, is expected to support market growth in the coming years. Furthermore, growing product applications in food microbiology and veterinary medicine will propel the digital PCR market in the forecast period. Moreover, the sudden outbreak and spread of the COVID-19 pandemic and the widespread use of different types of PCR devices in COVID-19 testing have created new prospects for the growth of different types of PCR markets, including the digital PCR market. In 2022, a total of 96,091,120 COVID-19 Cases were counted in the United States.

Rising Fund for Research and Development Activities in the Digital PCR

Due to the COVID19 pandemic, an unexpected demand was increased for Digital PCR in the healthcare and research institute sector. The pandemic has played an important role in enhancing the digital PCR market growth. The prevalence of infectious diseases like cancer has also increased, which accounts for the need for the diagnosis and detection of the disease. For this reason, funding in the research and development sector has also increased. Increased funding for R&D activities that include the use of digital PCR and Chip-based PCR for different purposes is expected to increase its use and open up new opportunities for global market expansion during the forecast period.

Market Segmentation

Global Digital PCR market is segmented into type, component, application, end-user, and by region. Based on type, the market can be segmented into Droplet Digital PCR, Chip Based Digital PCR, and Others. Based on components, the market can be segmented into Systems, Kits and Assays, Reagents, and Consumables. Based on application, the market can be differentiated into Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, and Others. Based on end-user, the market can be segmented into Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. In terms of country, the United States region is dominating the overall globe in the digital PCR market. According to Worldometer, as of December 26, 2022, around 102,236,095 confirmed COVID-19 cases have been reported in the United States. This can be ascribed to the increasing cost-effective COVID-19 testing technology in the healthcare sector.

Market Players

Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Genetron Holdings Limited, Naveris, Inc., SAGA Diagnostics, Precigenome LLC are some of the leading players operating in the Global Digital PCR Market.

Report Scope

In this report, Global Digital PCR market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Digital PCR Market, By Type:

  • Digital Droplet PCR
  • Chip Based on Digital PCR
  • Others

Digital PCR Market, By Component:

  • Systems
  • Kits and Assays
  • Reagents
  • Consumables

Digital PCR Market, By Application:

  • Oncology
  • Infectious Diseases
  • Rare Diseases
  • Reproductive Genetics
  • Others

Digital PCR Market, By End User:

  • Academic and Research Institutions
  • Biotechnology & Pharmaceutical Companies
  • Hospitals and Clinics
  • Others

Digital PCR Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Digital PCR Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital PCR Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Droplet Digital PCR, Chip Based Digital PCR, Others)
    • 5.2.2. By Component (Systems, Kits and Assays, Reagents and Consumables)
    • 5.2.3. By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)
    • 5.2.4. By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Component
    • 5.3.3. By Application
    • 5.3.4. By End User
    • 5.3.5. By Region

6. North America Digital PCR Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital PCR Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico Digital PCR Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada Digital PCR Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Digital PCR Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Digital PCR Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Digital PCR Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Digital PCR Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Digital PCR Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Digital PCR Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Digital PCR Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Digital PCR Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Digital PCR Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea Digital PCR Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan Digital PCR Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Digital PCR Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Digital PCR Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Digital PCR Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Digital PCR Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Digital PCR Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Digital PCR Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Digital PCR Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Digital PCR Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Digital PCR Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User
    • 10.3.4. Egypt Digital PCR Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Component
        • 10.3.4.2.3. By Application
        • 10.3.4.2.4. By End User
    • 10.3.5. Turkey Digital PCR Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Type
        • 10.3.5.2.2. By Component
        • 10.3.5.2.3. By Application
        • 10.3.5.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (As reported)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. Bio-Rad Laboratories, Inc.
    • 13.6.2. Fluidigm Corporation
    • 13.6.3. F. Hoffmann-La Roche AG
    • 13.6.4. Merck KGaA
    • 13.6.5. QIAGEN N.V.
    • 13.6.6. Thermo Fisher Scientific Inc.
    • 13.6.7. Genetron Holdings Limited
    • 13.6.8. Naveris, Inc.
    • 13.6.9. SAGA Diagnostics
    • 13.6.10. Precigenome LLC

14. Strategic Recommendations